Detalhe da pesquisa
1.
Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation.
Transpl Infect Dis
; 22(1): e13201, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31643129
2.
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Am J Med Genet A
; 173(4): 1017-1037, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168833
3.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
J Clin Invest
; 133(12)2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159273
4.
The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases.
Eur J Haematol
; 88(5): 406-15, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22309072
5.
Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma.
Eur J Haematol
; 84(4): 337-44, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20028416
6.
Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.
Exp Cell Res
; 315(14): 2471-8, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19410573
7.
Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment.
Eur J Haematol
; 82(1): 31-8, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19067746
8.
Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma.
Eur J Haematol
; 82(6): 440-9, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19220424
9.
A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency.
Fam Cancer
; 16(1): 67-71, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573199
10.
The potential of proteasome inhibitors in cancer therapy.
Expert Opin Investig Drugs
; 17(6): 879-95, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18491989